Axion Bio, Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors (NCT07159828) | Axion Bio, Inc | 2025-09-15 |
Track Axion Bio, Inc automatically
Every clearance here is in the API, with alerts when new ones post.